These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12627785)
1. Phosphorylcholine-coated stents. Lewis AL; Stratford PW J Long Term Eff Med Implants; 2002; 12(4):231-50. PubMed ID: 12627785 [TBL] [Abstract][Full Text] [Related]
2. A Review on Phosphorylcholine-Coated Stents. Lewis AL; Stratford PW J Long Term Eff Med Implants; 2017; 27(2-4):233-252. PubMed ID: 29773041 [TBL] [Abstract][Full Text] [Related]
3. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo. Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385 [TBL] [Abstract][Full Text] [Related]
4. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559 [TBL] [Abstract][Full Text] [Related]
5. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents. Grube E; Buellesfeld L Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588 [TBL] [Abstract][Full Text] [Related]
7. A stent is not just a stent: Stent construction and design do matter in its clinical performance. Lau KW; Johan A; Sigwart U; Hung JS Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045 [TBL] [Abstract][Full Text] [Related]
8. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536 [TBL] [Abstract][Full Text] [Related]
10. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model. Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility. Malik N; Gunn J; Shepherd L; Crossman DC; Cumberland DC; Holt CM J Invasive Cardiol; 2001 Mar; 13(3):193-201. PubMed ID: 11231644 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849 [TBL] [Abstract][Full Text] [Related]
13. Role of stent design and coatings on restenosis and thrombosis. Hara H; Nakamura M; Palmaz JC; Schwartz RS Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911 [TBL] [Abstract][Full Text] [Related]
14. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results. Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF; Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559 [TBL] [Abstract][Full Text] [Related]
15. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry. Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999 [TBL] [Abstract][Full Text] [Related]
16. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485 [TBL] [Abstract][Full Text] [Related]
17. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]. Silber S; Herdeg C Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314 [TBL] [Abstract][Full Text] [Related]
18. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
19. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents. Mrowietz C; Franke RP; Seyfert UT; Park JW; Jung F Clin Hemorheol Microcirc; 2005; 32(2):89-103. PubMed ID: 15764818 [TBL] [Abstract][Full Text] [Related]
20. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents. Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]